A Complimentary Continuing Education Lecture Series for Healthcare
Professionals
HADDON HEIGHTS, N.J., March 24 /PRNewswire/ -- Glioblastomas are the most common and most malignant type of glioma. Healthcare professionals face many challenges in the treatment of glioblastoma as therapy remains largely palliative, and mean length of survival in patients is less than one year.
Recent clinical trials have shown that combining surgery, radiation therapy and chemotherapy extends survival in a subset of patients, particularly when the chemotherapeutic agent temozolomide is included in the treatment approach. Other potentially promising therapies for glioblastoma under investigation include regional drug administration, targeted biological therapies, vaccines, and genomic profiling. As research continues, new agents for adult glioblastoma are expected to further extend survival.
To address the need for current education on glioblastoma, treatment strategies, challenges, and emerging therapies, Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a series of complimentary live educational lectures in institutions across the United States, as well as an online educational activity consisting of a virtual lecture presentation.
The Course Director for this continuing education opportunity is Dr. Marc C. Chamberlain, Professor of Neurology at the University of Washington and expert in the development of clinical trials for primary brain tumors. All lectures will be presented by experts in the treatment of glioblastoma. Continuing education credit will be offered for physicians, pharmacists and nurses.
Healthcare professionals can schedule a live lecture at their
institution by contacting RMEI:
Online: http://www.rmei.com/GBLectures
Toll-free Phone: 1-866-770-7634, ext. 337
Email: GBLectures@rmei.com
This continuing education opportunity is jointly sponsored by Robert Michael Educational Institute LLC and Postgraduate Institute of Medicine and is supported by an educational grant from Schering-Plough.
Robert Michael Educational Institute LLC is a full-service medical education company dedicated to providing comprehensive medical education to healthcare providers, patients, and caregivers. Our mission is to design programs that improve diagnosis and treatment through a variety of educational programming such as national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.
'/>"/>
| SOURCE Robert Michael Educational Institute LLC Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. New Rheumatoid Arthritis Drug Works for Adults, Children
2. Research on consequences: Hyperactive girls face problems as adults
3. Eating Disorders Program at Lucile Packard Childrens Hospital Expands to Include Young Adults
4. Cystic Fibrosis Foundation announces $5 million initiative to enhance care for adults with CF
5. Cystic Fibrosis Foundation Announces $5 Million Initiative to Enhance Care for Adults with CF - as Lifespan Increases
6. Depression: the symptoms in children are not like in adults
7. Dont Prescribe Antibiotics for Adult Sinus Woes
8. Rate of escalator injuries to older adults has doubled
9. Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life
10. The Attention Deficit Disorder Association and The HealthCentral Network Form Alliance to Develop New Online Resources for Adult ADHD
11. Emergency on-field treatment for neck injuries in young sports athletes no different than adults
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |